Skip to content

Clinical trials

Alzheimer Disease trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Chile Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20073
20085
20096
20101
20121
20131
20141
20152
20161
20173
20181
20191
20202
20213
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated14
Recruiting5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline9
Hoffmann-La Roche7
Pfizer7
Bristol-Myers Squibb3
Axovant Sciences Ltd.2
Eli Lilly and Company2
H. Lundbeck A/S2
Novartis Pharmaceuticals2
ACADIA Pharmaceuticals Inc.1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease42
Dementia6
Psychomotor Agitation3
Brain Diseases2
Cognitive Dysfunction2
Hallucinations2
Neurodegenerative Diseases2
Psychotic Disorders2
Central Nervous System Diseases1
Corticobasal Degeneration1

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.